Cost comparison of strategies for the management of venous thromboembolic event risk following laparotomy for ovarian cancer

Gynecologic Oncology

Volumn 122, Issue 3, 2011, Pages 467-472

  Teoh, Deanna ^a   Berchuck, Andrew ^a   Secord, Angeles Alvarez ^a   Lee, Paula S ^a   Lowery, William J ^a   Sfakianos, Gregory P ^a   Valea, Fidel A ^a   Myers, Evan R ^b   Havrilesky, Laura J ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cost analysis; Ovarian cancer; Thromboprophylaxis

Indexed keywords

HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; CARDIOVASCULAR EQUIPMENT; DEEP VEIN THROMBOSIS; FEMALE; HEALTH CARE COST; HUMAN; LAPAROTOMY; OVARY CANCER; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RISK; SEQUENTIAL PNEUMATIC COMPRESSION DEVICE; VENOUS THROMBOEMBOLISM;

COMPARATIVE EFFECTIVENESS RESEARCH; COST-BENEFIT ANALYSIS; DECISION SUPPORT TECHNIQUES; DECISION TREES; FEMALE; HEALTH CARE COSTS; HUMANS; LAPAROTOMY; MODELS, ECONOMIC; OVARIAN NEOPLASMS; RISK FACTORS; VENOUS THROMBOSIS;

EID: 80051524261     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2011.06.014     Document Type: Article

References (42)

1. L. Dainty, G.L. Maxwell, D.L. Clarke-Pearson, and E.R. Myers Cost-effectiveness of combination thromboembolism prophylaxis in gynecologic oncology surgery Gynecol Oncol 93 2004 366 373 (Pubitemid 38507603)
2. M.H. Einstein, D.M. Kushner, J.P. Connor, A.A. Bohl, T.J. Best, and M.D. Evans A protocol of dual prophylaxis for venous thromboembolism prevention in gynecologic cancer patients Obstet Gynecol 112 2008 1091 1097
3. Y. Matsuura, G. Robertson, D.E. Marsden, S.N. Kim, V. Gebski, and N.F. Hackner Thromboembolic complications in patients with clear cell carcinoma of the ovary Gynecol Oncol 104 2007 406 410 (Pubitemid 46135653)
4. A.O. Rodriguez, T. Wun, H. Chew, H. Zhous, D. Harvey, and R.H. White Venous thromboembolism in ovarian cancer Gynecol Oncol 105 2007 784 790 (Pubitemid 46734211)
5. S. Tateo, L. Mereu, S. Salamano, C. Klersy, M. Barone, and A.C. Spyropoulos Ovarian cancer and venous thromboembolic risk Gynecol Oncol 99 2005 119 125 (Pubitemid 41354592)
6. X. Wang, S. Fus, R.S. Freedman, and J.J. Kavanagh Venous thromboembolism syndrome in gynecological cancer Int J Gynecol Cancer 16 2006 458 471
7. M.A. Martino, E. Borges, E. Williamson, S. Siegfried, A.B. Cantor, and J. Lancaster Pulmonary embolism after major abdominal surgery in gynecologic cancer Obstet Gynecol 107 2006 666 671
8. M.H. Einstein, E.A. Pritts, and E.M. Hartenbach Venous thromboembolism prevention in gynecologic cancer surgery: a systematic review Gynecol Oncol 105 2007 813 819 (Pubitemid 46734212)
9. G.L. Maxwell, E.R. Myers, and D.L. Clarke-Pearson Cost-effectiveness of deep venous thrombosis prophylaxis in gynecologic oncology surgery Obstet Gynecol 95 2000 206 214 (Pubitemid 30045641)
10. A. Peedicayil, A. Weaver, X. Li, E. Carey, W. Cliby, and A. Mariani Incidence and timing of venous thromboembolism after surgery for gynecological cancer Gynecol Oncol 121 2011 64 69
11. D. Bergqvist, G. Agnelli, A.T. Cohen, A. Eldor, P.E. Nilsson, and A. Le Moigne-Amrani Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer N Engl J Med 346 2002 975 980 (Pubitemid 34983247)
12. I. Lausen, R. Jensen, L.N. Jorgensen, M.S. Rasmussen, K.M. Lyng, and M. Andersen Incidence and prevention of deep venous thrombosis occurring later after general surgery: randomized controlled study of prolonged thromboprophylaxis Eur J Surg 164 1998 657 663 (Pubitemid 28368781)
13. M.S. Rasmussen, L.N. Jorgensen, P. Wille-Jorgensen, J.D. Nielsen, A. Horn, and A.C. Mohn Prolonged prophylaxis with dalteparin to prevent late thromboembolic complications in patients undergoing major abdominal surgery: a multicenter randomized open-lable study J Thromb Haemost 4 2006 2384 2390 (Pubitemid 44575433)
14. A.Y. Lee, M.N. Levine, R.I. Baker, C. Bowden, A.K. Kakkar, and M. Prins Low-molecular-weight heparin versus a coumarin for prevention of recurrent venous thromboembolism patients with cancer N Engl J Med 349 2003 146 153 (Pubitemid 36818784)
15. M.S. Rasmussen, L.N. Jorgensen, and P. Wille-Jorgensen Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery Cochrane Database Syst Rev 2009 CD004318
16. Website http://www.ahrq.gov/qual/vtguide/vtguideapa.htm (accessed 7/1/10)
17. L.S. Elting, C.P. Escalante, C. Cooksley, E.B. Avritscher, D. Kurtin, and L. Hamblin Outcomes and cost of deep venous thrombosis among patients with cancer Arch Intern Med 164 2004 1653 1661 (Pubitemid 39037944)
18. C.W. Colwell Jr., P. Pulido, M.E. Hardwick, and B.A. Morris Patient compliance with outpatient prophylaxis: an observational study Orthopedics 28 2005 143 147 (Pubitemid 40305701)
19. P. Mismetti, S. Laporte, J.Y. Darmon, A. Buchmuller, and H. Decousus Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgery Br J Surg 88 2001 913 930 (Pubitemid 34015572)
20. C.T. Bradley, K.J. Brasel, J.J. Miller, and S.G. Pappas Cost-effectiveness of prolonged thromboprophylaxis after cancer surgery Ann Surg Oncol 17 2010 31 39
21. Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial Lancet 355 2000 1295 1302
22. C. Kearon, S.R. Kahn, G. Agnelli, S. Godhaber, G.E. Raskob, and A.J. Comerota Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition) Chest 133 2008 454S 545S (Pubitemid 351892971)
23. D.L. Clarke-Pearson, R.E. Coleman, I.S. Synan, W. Hinshaw, and W.T. Creasman Venous thromboembolism prophylaxis in gynecologic oncology: a prospective, controlled trial of two low-dose heparin Am J Obstet Gynecol 145 1983 606 613 (Pubitemid 13149421)
24. D.L. Clarke-Pearson, E. DeLong, I.S. Synan, J.T. Soper, W.T. Creasman, and R.E. Coleman A controlled trial of two low-dose heparin regimens for the prevention of postoperative deep vein thrombosis Obstet Gynecol 105 2007 223 227
25. A.S. Case, R.P. Rocconi, E.E. Partridge, and J.M. Straughn Jr. A cost-effectiveness analysis of chemotherapy for patients with recurrent platinum-sensitive epithelial ovarian cancer Gynecol Oncol 105 2007 223 227 (Pubitemid 46441465)
26. L.J. Havrilesky, A.A. Secord, K.M. Darcy, D.K. Armstrong, S. Kulasingam, and Gynecologic Oncology Group Cost effectiveness of intraperitoneal compared with intravenous chemotherapy for women with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study J Clin Oncol 26 2008 4144 4150
27. R.P. Rocconi, A.S. Case, and J.M. Straughn Role of chemotherapy for patients with recurrent platinum-resistant advanced epithelial ovarian cancer: a cost-effectiveness analysis Cancer 107 2006 536 543 (Pubitemid 44107214)
28. 2010 Red Book: Pharmacy's Fundamental Reference 2010 Medical Economics Company, Inc.
29. W.H. Geerts, D. Bergqvist, G.F. Pineo, J.A. Heit, C.M. Samama, and M.R. Lassen Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest 133 2008 381S 453S (Pubitemid 351894916)
30. W.H. Geerts, G.F. Pineo, J.A. Heit, D. Bergqvist, M.R. Lassen, and C.W. Colwell Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy Chest 126 2004 338S 400S (Pubitemid 39302602)
31. R.H. White The epidemiology of venous thromboembolism Circulation 107 2003 14 18
32. S.D. Reed, J.I. Radeva, D.B. Daniel, S.H. Mody, J.B. Forlenza, and R.S. McKenzie Economic evaluation of weekly epoeitin alfa versus biweekly darbepoeitin alfa for chemotherapy-induced anaemia: evidence from a 16-week randomized trial Pharmacoeconomics 24 2006 479 494 (Pubitemid 43765217)
33. S. Ramsey, R. Willke, A. Briggs, R. Brown, M. Buxton, and A. Chawla Good research practices for cost-effectiveness analysis alongside clinical trials: the ISPOR RCT-CEA Task Force report Value Health 8 2005 521 523
34. A. Sachdeva, M. Dalton, S.V. Amaragiri, and T. Lees Elastic compression stockings for prevention of deep vein thrombosis Cochrane Database Syst Rev 2010 CD001484
35. P. Wille-Jorgensen, M.S. Rasmussen, B.R. Andersen, and L. Borly Heparins and mechanical methods for thromboprophylaxis in colorectal surgery Cochrane Database Syst Rev 2003 CD001217
36. G.L. Maxwell, I. Synan, R.P. Hayes, and D.L. Clarke-Pearson Preference and compliance in postoperative thromboembolism prophylaxis among gynecologic oncology patients Obstet Gynecol 100 2002 451 455 (Pubitemid 35246130)
37. Noble Si Is long-term low-molecular-weight heparin acceptable to palliative care patients in the treatment of cancer-related venous thromboembolism? A qualitative study Palliat Med 19 2005 197 201
38. M.H. Huo, and J. Muntz Extended thromboprophylaxis with low-molecular-weight heparins after hospital discharge in high-risk surgical and medical patients: a review Clin Ther 31 2009 1129 1141
39. Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep vein thrombosis in elective cancer surgery: a double-blind randomized multicentre trial with venographic assessment. ENOXACAN Study Group Br J Surg 84 1997 1099 1103
40. N. Martel, J. Lee, and P.S. Wells Risk for heparin-induced thrombocytopenia with unfractionated and low-molecular-weight heparin thromboprophylaxis: a meta-analysis Blood 106 2005 2710 2715 (Pubitemid 41510744)
41. T.E. Warkentin, and A. Greinacher Heparin-induced thrombocytopenia: recognition, treatment and prevention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy Chest 126 2004 311S 337S (Pubitemid 39297959)
42. American Congress of Obstetricians and Gynecologistis Prevention of deep vein thrombosis and pulmonary embolism (ACOG Practice Bulletin no. 84) Obstet Gynecol 110 2007 429 440